Page last updated: 2024-09-05
ly 300164 and gyki 47261
ly 300164 has been researched along with gyki 47261 in 1 studies
Compound Research Comparison
| Studies (ly 300164) | Trials (ly 300164) | Recent Studies (post-2010) (ly 300164) | Studies (gyki 47261) | Trials (gyki 47261) | Recent Studies (post-2010) (gyki 47261) |
|---|---|---|---|---|---|
| 73 | 7 | 12 | 7 | 0 | 3 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Berzsenyi, P; Csuzdi, E; Hazai, I; Horváth, G; Lengyel, G; Migléczi, K; Pallagi, I; Sólyom, S | 1 |
Other Studies
1 other study(ies) available for ly 300164 and gyki 47261
| Article | Year |
|---|---|
Potential metabolites of a condensed 2,3-benzodiazepine derivative.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepines; Drug Evaluation, Preclinical; Hydroxylation; Liver; Neuroprotective Agents; Perfusion; Rats; Structure-Activity Relationship | 2005 |